Stéphane Bancel
Stéphane Bancel (born 1972/1973) is a French businessman and the CEO and 9% owner of Moderna, an American biotechnology company.
Stéphane Bancel | |
---|---|
Born | 1972/1973 (age 47–48)[1] France |
Nationality | French |
Education | École Centrale Paris University of Minnesota Harvard Business School |
Occupation | Businessman |
Known for | CEO and 9% owner of Moderna |
Net worth | US$1.0 billion (April 2020)[1] |
Title | 2013– |
Early life
Bancel was born in France and earned his master's degrees in engineering from École Centrale Paris, and the University of Minnesota.[1] He went on to earn an MBA from Harvard Business School.[2]
Career
Bancel was a sales director at Eli Lilly and Company, eventually becoming head of operations for Belgium.[2] In 2007, he became CEO of French diagnostics company BioMérieux.[2]
In 2011 Bancel joined Moderna, becoming CEO. Stat news, reported that Bancel led a highly secretive culture with little outside review of its science or research.[2]
Personal life
In April 2020, with the Moderna share price rising on news of imminent phase 2 human trials for its potential COVID-19 vaccine, Bancel's stake of about 9% became worth over $1 billion.[1]
References
- Tognini, Giacomo (3 April 2020). "Moderna CEO Stéphane Bancel Becomes A Billionaire As Stock Jumps On Coronavirus Vaccine News". Forbes. Retrieved 4 April 2020.
- Garade, Damien (13 September 2016). "Ego, ambition, and turmoil: Inside one of biotech's most secretive startups". Stat. Retrieved 18 May 2020.